Dynavax Investor Relations Material
Latest events
Q2 2025
Dynavax
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dynavax Technologies Corporation
Access all reports
Dynavax Technologies Corporation is a biopharmaceutical company that develops and commercializes novel vaccines and immunotherapies. The company focuses on leveraging its proprietary Toll-like Receptor (TLR) immune modulation technology to enhance the efficacy of its products. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.
Key slides for Dynavax Technologies Corporation
Q1 2025
Dynavax Technologies Corporation
Q1 2025
Dynavax Technologies Corporation
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
DVAX
Country
🇺🇸 United States